Paediatric Consumer Health in Nigeria

PROSPECTS

Growth in line with falling infant mortality rate

Paediatric consumer health achieved more growth in 2019 than it did in 2018 because of the larger population of women giving birth on a daily basis. The infant mortality rate over the years had been on the increase because infants had been susceptible to infections due to their weak/underdeveloped immune systems and lack of good healthcare facilities.

Paediatric analgesics and paediatric cough/cold remedies lead in value terms

Paediatric analgesics maintained the lead in paediatric consumer health in value terms in 2019. Several erroneous beliefs contributed to inadequate focus on children such as the assumption that children did not experience pain to the same extent that adults do, because of their immature nervous system, or that children would not remember the pain.

Future growth certain due to increased birth rates

The performance of paediatric consumer health is being positively affected by the increase in the birth rate, which is expected to continue in the long term. In addition, several other positive factors are expected to have an impact on paediatric consumer health in Nigeria as a favourable market coupled with consumers regaining their purchasing power is expected.

COMPETITIVE LANDSCAPE

Consumers tend to prefer recognised brands

While paediatric consumer health continued to grow, competition remained relatively saturated. Nigerians tend to prefer to purchase brands that they recognise or that are recommended to them by family, friends or a medical professional.

Emzor Pharmaceutical Industries Ltd leads paediatric consumer health

Domestic player Emzor Pharmaceutical Industries Ltd leads paediatric consumer health in Nigeria at the end of the review period; this was made possible by its high-ranking brands in paediatric acetaminophen, Emcap Paracetamol Suspension and Emzor Paracetamol Syrup. In paediatric cough/cold remedies, Emzolyn Cough Syrup for Children has helped the company maintain its category leadership role.

New product launches increase competition

Paediatric consumer health has witnessed a number of new product launches. Moxie, a range of children medicines, was recently introduced into the Nigerian market by Pharmalliance.

Files are delivered directly into your account within a few minutes of purchase.